Videnovic A, Amara AW, Comella C, Schweitzer PK, et al. Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial. Mov Disord 2021 Jun 30. doi: 10.1002/mds.28702.
PMID: 34191352